BASSAGANYA-RIERA JOSEP (Chairman, President and CEO) sold 2.4% of their position (125K shares) of LANDOS BIOPHARMA, INC. on the open market
Open‑market sale worth $645.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 12/15/2021ACC: 0001843575-21-000009
DirectorOfficer10% Owner· Chairman, President and CEO
Since Feb 2021
-125K
Net shares
Net seller
$645.2K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
125K disposed
Non-Derivative Transactions3
common stock
Indirect
Shares
−40K
Price / share
$5.37
Trade value
$214.84K
% of position
0.8%
12/13/2021
5.27M→5.23M
common stock
Indirect
Shares
−42K
Price / share
$5.10
Trade value
$214.28K
% of position
0.8%
12/14/2021
5.23M→5.19M
common stock
Indirect
Shares
−43K
Price / share
$5.02
Trade value
$216.03K
% of position
0.8%
12/15/2021
5.19M→5.15M
Total
Net shares
−125K
Net value
-$645.16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| common stock Indirect | 12/13/2021 | S · Sale | −40K | $5.37 | $214.84K | 0.8% | 5.27M | 5.23M |
| common stock Indirect | 12/14/2021 | S · Sale | −42K | $5.10 | $214.28K | 0.8% | 5.23M | 5.19M |
| common stock Indirect | 12/15/2021 | S · Sale | −43K | $5.02 | $216.03K | 0.8% | 5.19M | 5.15M |
| Total | −125K | -$645.16K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
common stock
IndirectShares owned823.96K
common stock
IndirectShares owned786.30K
common stock
IndirectShares owned766.40K
Total
2.38M indirect2.38M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| common stock | 823.96K | Indirect |
| common stock | 786.30K | Indirect |
| common stock | 766.40K | Indirect |
| Total | 2.38M | 2.38M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported